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Abstract
IMPORTANCE Heated tobacco products (HTPs) are promoted as less harmful than combustible
cigarettes but epidemiological evidence is scarce, especially in youth.
OBJECTIVE To investigate the associations of persistent respiratory symptoms with HTP use,
cigarette use, and dual use among Hong Kong youth.

Key Points
Question Is heated tobacco product
(HTP) use associated with fewer
respiratory symptoms when compared
with cigarette smoking in youth?
Findings In this cross-sectional study
with 33 627 youths from 88 secondary

DESIGN, SETTING, AND PARTICIPANTS This was a territorywide cross-sectional school-based

schools, persistent respiratory

survey conducted from October 2018 to July 2019 using an anonymous questionnaire. Schools were

symptoms were more prevalent in HTP

randomly invited from a proportionate stratified sample in all 18 districts of Hong Kong. Poisson

users than nonusers, especially among

regression models using generalized estimating equations yielded adjusted prevalence ratios (APRs)

never and former cigarette smokers.

of respiratory symptoms in (1) former and current HTP (vs never) users in the whole sample and

Persistent respiratory symptoms were

stratified by cigarette use status and (2) exclusive HTP and dual users vs exclusive cigarette users.

associated with exclusive ever HTP use

Statistical analysis was performed from October 2020 to March 2021.

and ever dual use vs exclusive ever
cigarette smoking, and comparable in

EXPOSURES Former and current use of cigarettes, HTPs, e-cigarettes, and other tobacco products.

current users of HTPs and cigarettes.
Meaning Youth HTP and cigarette use

MAIN OUTCOMES AND MEASURES Respiratory symptoms for 3 consecutive months in the past
12 months.

were similarly associated with
respiratory symptoms, suggesting that
both HTP and cigarette use should be

RESULTS The study included 33 627 students with a mean (SD) age of 14.8 (1.9) years; 51.3% (18 171)

prevented in youth.

were boys. Respiratory symptoms were reported by 16.3% (n = 5549) of all students, 29.3%
(n = 226) of current users of e-cigarettes, 31.2% (n = 314) of current users of cigarettes, and 33.5%
(n = 179) of current users of HTPs. Respiratory symptoms were associated with former (APR, 1.30;
95% CI, 1.06-1.59) and current (APR, 1.59; 95% CI, 1.23-2.06) vs never HTP use and current vs never
cigarette use (APR, 1.50; 95% CI, 1.30-1.74) after adjusting for various tobacco use. Associations
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between respiratory symptoms and current vs never HTP use were observed in never (APR, 1.88;
95% CI, 1.36-2.59) and former (APR, 2.15; 95% CI, 1.12-4.12) cigarette users, but not in current
cigarette users (APR, 1.24; 95% CI, 0.97-1.59). Respiratory symptoms were associated with exclusive
ever HTP use (APR, 1.46, 95% CI, 1.15-1.86) and ever dual use (APR, 1.29; 95% CI, 1.08-1.54) vs
exclusive ever cigarette use. There was no association between exclusive current HTP (vs cigarette)
use and respiratory symptoms (1.40; 95% CI, 0.93-2.11).
CONCLUSIONS AND RELEVANCE This cross-sectional study found that former and current HTP use
were associated with persistent respiratory symptoms among youth, especially among never and
former cigarette users. Respiratory symptoms were more prevalent in ever exclusive HTP users and
ever dual users than ever exclusive cigarette users. These findings suggest that using HTPs instead of
cigarettes may not reduce health risks.
JAMA Network Open. 2021;4(7):e2117055. doi:10.1001/jamanetworkopen.2021.17055
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Introduction
Heated tobacco products (HTPs) heat processed tobacco to generate an aerosol for inhalation and
have been marketed as less harmful than combustible cigarettes. Studies have shown that exposure
to harmful and potentially harmful chemicals can be significantly reduced if smokers switch
completely from combustible cigarettes to HTPs.1 However, whether reduced exposure would result
in reduced harms to human health has not been confirmed.
The potential for harm reduction by instead using HTPs is controversial. Laboratory tests
showed that nicotine and total particulate matter in mainstream HTP aerosol were comparable to
cigarette smoke.2 HTPs generated chemicals that were present in cigarette smoke, although at lower
levels, but also chemicals that were absent in cigarette smoke, such as glycerol and the lethal
formaldehyde cyanohydrin.3-5 Experiments on rats conducted by the tobacco industry have shown
that exposure to HTP aerosol was associated with substantial pulmonary inflammation and
immunomodulation.6 In addition, rats exposed to HTP aerosol had similar impairments of vascular
endothelial function, and their serum nicotine levels (immediately after exposure) were 3.5-fold
higher than those exposed to cigarette smoke (70.3 [SD, 26.3] ng/mL in the HTP group and 15.0 [SD,
7.7] ng/mL in the cigarette group).7
Evidence on the health effects of HTP use in humans is limited. Glantz8 conducted a secondary
analysis with the trial results submitted by the industry, and found no differences in most of the
biomarkers of potential harm (23 of 24 in US adults, 10 of 13 in Japanese adults) between cigarette
smokers and those who switched to HTPs. Moazed et al6 also analyzed these documents and found
no improvements in pulmonary inflammation or lung function in cigarette smokers who switched to
HTPs. Another trial in 50 males by Pataka et al9 showed significant decrease in oximetry (oxygen
saturation), and increase in exhaled carbon monoxide and airway resistance immediately after HTP
use in both cigarette smokers and nonsmokers. In an online survey of 102 former or current smoking
adults who used HTPs, sore throat (n = 5), cough (n = 3), and headache (n = 3) were reported after
using HTPs.10 Another online survey of 8784 Japanese individuals aged 15 to 73 years showed that
asthma attack and chest pain were associated with exposure to secondhand smoke of HTPs (vs
cigarettes) in the past year.11 Recently, 3 acute eosinophilic pneumonia cases have been linked to HTP
use—2 male youths aged 16 and 20 years old,12,13 and a woman aged 47 years who switched from
cigarettes to HTPs.14 By searching “(heated tobacco product OR heat-not-burn) AND (child OR
adolescent)” in PubMed and Web of Science until May 8, 2021, we only found 2 studies,15,16 both
based on the Korea Youth Risk Behavior Survey in 2018, with statistical test results, showing that ever
use of HTPs was associated with current asthma (adjusted odds ratio [AOR], 3.8; 95% CI, 1.5-9.6) in
never users of cigarettes and e-cigarettes, but not with current allergic rhinitis.
The tobacco industry has sought to launch HTPs in Hong Kong with a much lower tax than
cigarettes, but no HTPs have been licensed to be sold (as tobacco products).17,18 However, untaxed
HTPs are available in online and physical stores;18 among Hong Kong youth, 2.3% had ever used HTPs
and 0.5% currently used HTPs in 2019.19 As youth are more vulnerable to air pollutants and tobacco
smoke than adults,20 youth HTP use is a great public health concern. Therefore, we aimed to
investigate the associations between HTP use and respiratory symptoms considering other tobacco
use in Hong Kong youth.

Methods
Study Design and Participants
The School-Based Survey on Smoking is the largest territorywide biennial smoking survey in
secondary school students (US grades 7 to 12) in Hong Kong. The present round was conducted from
October 2018 to July 2019. Details of the survey methods have been reported.21,22 Briefly, schools
were invited from a stratified random sample in all 18 districts in Hong Kong, in proportion to the total
number of schools in each district. Each participating school was compensated with a book coupon
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worth HK $500 (US $65). Parental consent was sought before the survey. All the parents from
participating schools received an invitation letter via students, and declining parents were to ask
students to return a blank answer sheet during the survey. Students’ participation was voluntary
even with parental consent. Students answered a paper-and-pencil questionnaire in classrooms
within one class session. At least one trained research assistant per grade was available to coordinate
and answer students’ enquiries. To encourage candid reporting, teachers avoided patrolling near
students, and a separate anonymous answer sheet was used. Completed answer sheets were
immediately sealed in front of the students and collected by research assistants. In total, 34 063
students in 88 schools returned the answer sheets, with a response rate of 94% at student-level and
23% at school-level. Given that most students were ethnic Hong Kong/Cantonese but born in
different places (eg, Hong Kong, mainland China, Macau), we asked their place of birth instead of
race/ethnicity. Ethics approval of this survey was obtained from the institutional review board of the
University of Hong Kong/Hospital Authority Hong Kong West Cluster. This study followed the
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting
guideline for cross-sectional studies.23

Tobacco Use Measures
In the beginning of the questionnaire, we provided a brief introduction to each tobacco product:
electronic cigarettes refer to electronic devices that heat a chemical solution to produce an aerosol;
heated tobacco products refer to electronic devices that heat up tobacco sticks to produce an
aerosol. Then the use of combustible cigarettes (CCs), HTPs, e-cigarettes and other tobacco products
(eg, waterpipe, cigar, snus, etc.) were separately assessed by “Please choose one sentence which
suits you most regarding the product” (options: “I have never used it,” “I have used it once or a few
times,” “I used to use it occasionally, but have quit now,” “I used to use it every day, but have quit
now,” “I use it occasionally,” or “I use it every day”). Ever use was defined as any use or trying of the
product,24 and thus students who chose “I have never used it” were classified as never users, and
otherwise as ever users. Current use of each product was assessed by “On how many of the past 30
days did you use the product?” (options: 0, 1-2, 3-5, 6-9, 10-19, 20-29, or 30 days). Ever users who
used the product for at least 1 day in the past 30 days was classified as current users, and otherwise
as former users.24

Outcome Ascertainment
We asked whether students had frequent cough or phlegm for 3 consecutive months in the past 12
months (options: yes or no). Daily respiratory symptoms such as cough, congestion, or phlegm, for at
least 3 months in a row are indicative of chronic bronchitis in children.25 These persistent symptoms
have been associated with environmental pollutants and cigarette smoking, which can reflect
pulmonary health and predict chronic respiratory diseases.26-28 Therefore, we used them as a simple
and practical indicator of short-term health impacts of HTP use.22

Covariates
We also assessed exposure to secondhand smoke at home by “On how many of the past 7 days has
someone used smoking products near you at home?” (options: 0, 1, 2, 3, 4, 5, 6, or 7 days) and alcohol
drinking by “Did you drink any alcoholic beverages in the past 12 months?” (options: yes or no).
Sociodemographic characteristics included sex, age, grade, and perceived family affluence.29,30

Statistical Analysis
We calculated the proportions of respiratory symptoms by sociodemographic characteristics,
secondhand smoke exposure at home, and alcohol drinking, weighted by sex, age, and grade
distribution of the underlying population provided by the Education Bureau of the Hong Kong Special
Administrative Region Government. As other tobacco use is linked to both HTP use and respiratory
symptoms,28,31 we examined the associations between HTP use and respiratory symptoms in 3 ways:
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(1) associations between HTP use (former and current vs never) and respiratory symptoms, adjusting
for other tobacco use; (2) associations between HTP use (former and current vs never) and
respiratory symptoms by CC use status (never, former, and current), adjusting for other tobacco use;
and (3) associations of exclusive HTP use and dual use with respiratory symptoms compared with
exclusive CC use, separately for ever and current use, and adjusting for other tobacco use. In
association analyses, Poisson regression models were fitted and robust standard errors were
calculated using generalized estimation equations accounting for school clustering effects32,33 with
R version 4.0.0 (R Project for Statistical Computing) package gee (version 4.13-20). We also adjusted
for the background characteristics which were associated with respiratory symptoms, as they were
common confounders in the association between tobacco use and health, including sex, perceived
family affluence, number of days exposed to secondhand smoke at home in the past 7 days, and
alcohol drinking in the past 12 months.34-36 The present analysis excluded 72 students (0.2% of
34 063) with higher than 50% missing items and 364 students (1.1% of 34 063) with missing data on
respiratory symptoms, leaving a total of 33 627 students included in the study. Missing rates were
less than 0.3% for all other variables used in the present analyses.
All statistical tests were 2-sided with P < .05 indicating statistical significance. Statistical analysis
was performed from October 2020 to March 2021.

Results
The study sample of 33 627 students had a mean (SD) age of 14.8 (1.9) years; 18 171 (51.3%) were
boys. Respiratory symptoms were reported by 16.3% of the students (n = 5549), and the proportions
were higher in boys (3253 [17.8%]), the least-affluent families (1736 [18.6%]), students with more
mean (SD) days of exposure to secondhand smoke at home (1.6 [2.7] days vs 1.4 [2.6] days), and
alcohol drinkers (2868 [18.1%]) (P values < .001), but did not differ by age or grade (Table 1).
Respiratory symptoms were reported by 31.2% (n = 314) of current users of cigarettes, 33.5%
(n = 179) of current users of HTPs, and 29.3% (n = 226) of current users of e-cigarettes. Models 1 and
2 in Table 2 show that respiratory symptoms were associated with former and current use of any
tobacco products. After mutually adjusting for use of each product (model 3), respiratory symptoms
were associated with former (adjusted prevalence ratio [APR], 1.30; 95% CI, 1.06–1.59) and current
(APR, 1.59; 95% CI, 1.23–2.06) (vs never) HTP use (P value for trend < .001), and with current (vs

Table 1. Background Characteristics and Respiratory Symptoms of the Sample
All respondents, No. (%)a
(N = 33 627)

Students with respiratory
symptoms, No. (%)a (n = 5549)

Boys

18 171 (51.3)

3253 (17.8)

Girls

15 456 (48.7)

2296 (14.6)

14.8 (1.9)

14.8 (1.9)

1

6206 (17.9)

1024 (16.5)

2

6563 (17.1)

1082 (16.6)

Characteristic

P valueb

Sex

Age, mean (SD), y

<.001
.71

Grade, secondary

3

6666 (16.6)

Abbreviation: SHS, secondhand smoke.

1056 (15.6)

4

6197 (16.4)

1068 (17.0)

5

5527 (16.1)

922 (16.3)

6

2468 (15.9)

397 (15.6)

a

Proportions unless otherwise stated, weighted by
sex, age, and grade distribution of the underlying
population provided by the Education Bureau of the
Hong Kong SAR Government.

b

P values were differences of respiratory symptoms
by sex, perceived family affluence, and alcohol
drinking from χ2 test, and linear trends of respiratory
symptoms by age, grade, and days of secondhand
smoke exposure.

c

Mean (SD) days of secondhand smoke exposure at
home in the past 7 days in all respondents and in
those who experienced respiratory symptoms.

.74

Perceived family affluence
Relatively poor

9132 (27.1)

1736 (18.6)

Average

19 611 (58.7)

3000 (15.2)

Relatively rich

4779 (14.2)

791 (16.5)

<.001

SHS exposure, mean (SD), dc 1.4 (2.6)

1.6 (2.7)

<.001

Alcohol drinking

2868 (18.1)

<.001

15 460 (47.0)
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never) cigarette use (APR, 1.50; 95% CI, 1.30–1.74). No interactions of tobacco use with secondhand
smoke exposure or sex were found in the associations. Former and current use of e-cigarettes were
not independently associated with respiratory symptoms after adjusting for use of cigarettes and
HTPs. Therefore, we only classified the sample by cigarette and HTP use in the following analyses,
and included use of e-cigarettes and other tobacco products as a covariate in the fully
adjusted models.
Table 3 shows that, in never CC users, former (APR, 1.69; 95% CI, 1.30-2.20) and current (APR,
1.88, 1.36-2.59) HTP use were associated with respiratory symptoms compared with never HTP use.
In former CC users, current (vs never) HTP use was associated with respiratory symptoms (APR, 2.15;
95% CI, 1.12-4.12), but there was no association for former (vs never) HTP use (APR, 1.29; 95% CI,
0.95-1.75) (P = .10). In current CC users, the APRs of respiratory symptoms in former (APR, 1.10; 95%
CI, 0.78-1.54) and current (APR, 1.24; 95% CI, 0.97-1.59) (v never) HTP users were not statistically
significant. The APRs of respiratory symptoms increased with HTP use status (never, former and

Table 2. Associations of Respiratory Symptoms With Various Tobacco Product Use
Students with respiratory
symptoms, No. (%)

Product

Model 1, PR
(95% CI)a

Model 2, PR
(95% CI)b

Model 3, PR
(95% CI)c

CC
Never

4812 (15.8)

1 [Reference]

1 [Reference]

1 [Reference]

Former

416 (19.8)

1.26 (1.14-1.38)

1.11 (1.01-1.23)

1.07 (0.96-1.20)

Current

314 (31.2)

1.98 (1.78-2.19)

1.75 (1.58-1.94)

1.50 (1.30-1.74)

P for trend

NA

<.001

<.001

<.001

Never

5255 (16.1)

1 [Reference]

1 [Reference]

1 [Reference]

Former

107 (27.9)

1.74 (1.46-2.07)

1.52 (1.28-1.80)

1.30 (1.06-1.59)

Current

179 (33.5)

2.08 (1.80-2.41)

1.87 (1.61-2.17)

1.59 (1.23-2.06)

P for trend

NA

<.001

<.001

<.001

HTP

Abbreviations: CC, combustible cigarette; HTP, heated
tobacco product; NA, not applicable; PR,
prevalence ratio.
a

Adjusted for school clustering.

b

Adjusted for model 1 variable, sex, perceived family
affluence (categorical), days of secondhand smoke
exposure, and alcohol drinking. No interactions
between secondhand smoke exposure and use of
CCs, e-cigarettes, HTPs, or other tobacco products.
No interactions between sex and use of CCs,
e-cigarettes, HTPs, or other tobacco products.

c

Adjusted for model 2 variables and use of CCs,
e-cigarettes, HTPs, and other tobacco products
(never, former, and current). No interactions
between secondhand smoke exposure and use of
CCs, e-cigarettes, HTPs, or other tobacco products.
No interactions between sex and use of CCs,
e-cigarettes, HTPs, or other tobacco products.

e-Cigarettes
Never

4946 (16.0)

1 [Reference]

1 [Reference]

1 [Reference]

Former

369 (20.2)

1.26 (1.14-1.40)

1.13 (1.02-1.25)

0.98 (0.88-1.10)

Current

226 (29.3)

1.84 (1.58-2.13)

1.63 (1.40-1.88)

0.96 (0.78-1.19)

P for trend

NA

<.001

<.001

.75

Other tobacco
products
Never

5181 (16.1)

1 [Reference]

1 [Reference]

1 [Reference]

Former

176 (24.4)

1.52 (1.30-1.77)

1.33 (1.14-1.55)

1.09 (0.91-1.30)

Current

182 (30.0)

1.86 (1.59-2.18)

1.67 (1.43-1.95)

0.86 (0.66-1.12)

P for trend

NA

<.001

<.001

.84

Table 3. Associations Between HTP Use and Respiratory Symptoms by Cigarette Use
CC
Never

Former

HTP

Students with respiratory
symptoms, No. (%)

Model 1, PR
(95% CI)a

Model 2, PR
(95% CI)b

Model 3, PR
(95% CI)c

Abbreviations: CC, combustible cigarette; HTP, heated
tobacco product; NA, not applicable; PR,
prevalence ratio.

Never

4755 (15.7)

1 [Reference]

1 [Reference]

1 [Reference]

Former

30 (29.1)

1.86 (1.43-2.41)

1.67 (1.29-2.15)

1.69 (1.30-2.20)

a

Adjusted for school clustering.

Current

27 (33.8)

2.15 (1.66-2.78)

1.93 (1.47-2.53)

1.88 (1.36-2.59)

b

P for trend

NA

<.001

<.001

<.001

Adjusted for model 1 variable, sex, perceived family
affluence (categorical), days of secondhand smoke
exposure, and alcohol drinking. No interactions
between secondhand smoke exposure and use of
CCs or HTPs. No interactions between sex and use of
CCs or HTPs.

c

Adjusted for model 2 variables and use of CCs, HTPs,
and other tobacco products (eg, e-cigarettes) (never,
former, and current). No interactions between
secondhand smoke exposure and use of CCs, HTPs,
or other tobacco products. No interactions between
sex and use of CCs, HTPs, or other tobacco products.

Never

362 (19.1)

1 [Reference]

1 [Reference]

1 [Reference]

Former

39 (23.9)

1.25 (0.94-1.67)

1.20 (0.91-1.59)

1.29 (0.95-1.75)

Current

13 (36.1)

1.89 (1.11-3.22)

1.92 (1.12-3.28)

2.15 (1.12-4.12)

P for trend

NA

.008

.01

.008

142 (29.2)

1 [Reference]

1 [Reference]

1 [Reference]

Former

38 (31.4)

1.09 (0.78-1.52)

1.08 (0.76-1.55)

1.10 (0.78-1.54)

Current

153 (32.8)

1.13 (0.93-1.37)

1.22 (1.00-1.50)

1.24 (0.97-1.59)

P for trend

NA

.13

.22

.21

Current Never
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current) among never and former CC users (P values for trends ⱕ .01), but showed no marked trend
among current CC users (P for trend = .21). When using never users of both products as the
reference, any use of HTPs or cigarettes was associated with respiratory symptoms (eTable in the
Supplement).
Table 4 shows that respiratory symptoms were associated with exclusive ever HTP use (APR,
1.46; 95% CI, 1.15-1.86) and ever dual use (APR, 1.29; 95% CI, 1.08-1.54) vs exclusive ever CC use. As
regards current use, the APRs were not statistically significant for exclusive current HTP use (APR,
1.40; 95% CI, 0.93-2.11) and current dual use (APR, 1.19; 95% CI, 0.94-1.49) compared with exclusive
current CC use.

Discussion
To our knowledge, this cross-sectional study provided the first evidence that former and current HTP
use were associated with respiratory symptoms in youth, especially in never cigarette users. In
former cigarette users, respiratory symptoms were associated with current HTP use, but were not
associated with former HTP use. We also compared the prevalence of respiratory symptoms
between HTP use and cigarette use, and found that exclusive ever HTP users and ever dual users of
both products had even higher APRs of respiratory symptoms than exclusive ever cigarette users.
HTP use in Hong Kong appeared later than many Western countries, and young users might have
shorter use history on average, but using persistent respiratory symptoms as the outcome has
allowed us to detect its health hazards. Only the Korea Youth Risk Behavior Survey in 2018 reported
the health impacts of HTP use in youth,15,16 showing that ever HTP use (never cigarette and
e-cigarette use, regardless of other tobacco use) was associated with past-year asthma, but not with
past-year allergic rhinitis.
We found former and current HTP use were associated with respiratory symptoms after
adjusting for use of cigarettes, e-cigarettes, and other tobacco products. In never cigarette users, the
prevalence of respiratory symptoms in former and current HTP users increased by 69% and 88%
compared with never HTP users. In former cigarette users, current HTP use was still associated with
higher risks of respiratory symptoms, suggesting that switching from combustible cigarette smoking
to HTP use did not eliminate the adverse health outcomes. In current cigarette users, the risks of
respiratory symptoms for HTP use were not significantly greater, suggesting that HTP use did not
provide protection for current smokers who dually used HTPs and combustible cigarettes. These
results were consistent with those of a 90-day trial conducted by the tobacco industry showing that
switching to HTPs did not change pulmonary inflammation or function in cigarette smokers.6 Both
the International Tobacco Control Survey in Japanese adults and our previous study in Hong Kong
youth showed that HTPs may reinforce nicotine dependence rather than serving as a cessation aid,

Table 4. Respiratory Symptoms in Exclusive and Dual Users of Cigarettes and HTPs
Variable

Students with respiratory
symptoms, No. (%)

Model 1, PR
(95% CI)a

Model 2, PR
(95% CI)b

Model 3, PR
(95% CI)c

Ever use status
Exclusive CC use

507
(21.3)

1 [Reference]

1 [Reference]

1 [Reference]

Exclusive HTP use

47
(32.2)

1.52
(1.21-1.91)

1.52
(1.21-1.91)

1.46
(1.15-1.86)

Dual use

217
(31.0)

1.46
(1.24-1.71)

1.44
(1.24-1.68)

1.29
(1.08-1.54)

Current use status
Exclusive CC use

180
(29.7)

1 [Reference]

1 [Reference]

1 [Reference]

Exclusive HTP use

26
(38.8)

1.31
(0.90-1.91)

1.37
(0.92-2.04)

1.40
(0.93-2.11)

Dual use

153
(32.8)

1.11
(0.93-1.32)

1.20
(1.00-1.44)

1.19
(0.94-1.49)
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because cigarette consumption did not vary between exclusive smokers and those who partially
switched to HTPs.37,38
The APR of respiratory symptoms for exclusive ever HTP use was even larger than that for
exclusive ever cigarette use. A similar pattern was reported in the Korean youth study: the AOR of
past-year asthma was 3.59 (95% CI, 1.47-8.78) in exclusive HTP users and 1.30 (95% CI, 1.08-1.56) in
exclusive cigarette users.16 The potential health hazards of youth HTP use in real-world conditions
could be drastically underestimated if they were to be labeled as modified risk tobacco products.
Lower concentrations of toxicants do not necessarily lead to less risk. First, due to less
harshness than combustible cigarettes and kid-friendly flavors, HTPs can be easier to initiate and
more appealing to youth who do not use or lightly use nicotine, and facilitate persistent and frequent
use.39-41 Second, despite no flames, the I Quit Original Smoking (IQOS) tobacco product sticks (Philip
Morris International), with similar ingredients to cigarettes, are always charred because of pyrolysis
and generate volatile and semi-volatile toxicants as in cigarette smoke, challenging the claim of “heat
but not burn.”4 Third, harmful constituents are increasingly confirmed in HTPs. Many harmful and
potentially harmful substances in the aerosol of IQOS are more than 50% higher than cigarette
smoke, such as glycerol, α,β-unsaturated carbonyl compounds, 1,2-dicarbonyl compounds, furans
and epoxides.3,5 HTPs also contain highly toxic formaldehyde cyanohydrin that is absent in cigarette
smoke.4 Finally, HTP use would have detrimental effects similar to cigarette smoking. Evidence has
shown that HTP aerosol impairs human airway cell homeostasis by increasing oxidative stress,
inflammation and airway remodeling, which plays a key role in many chronic respiratory diseases
caused by cigarette smoke.42 Despite scarce evidence from population-based studies, potential
adverse health effects of HTP use have been shown by in vitro and in vivo experiments, case reports
and a few small-scale human trials.6-9,12-14
The outbreak of e-cigarette or vaping product use-associated lung injury (EVALI) in the US was
linked to inhaled Vitamin E acetate and/or tetrahydrocannabinol,43 and the pathology of the 3 HTP
use-related acute eosinophilic pneumonia cases remain undetermined,12-14 alerting that we know
little about the hazards of new tobacco products, especially their long-term effects. Our results in
Hong Kong youth found that the health risks of e-cigarette use were mainly associated with dual use
of cigarettes and HTPs, but use of new tobacco products mimics the hand-to-month smoking
behaviors, which can renormalize tobacco use and act as a gateway to cigarette smoking.44 The
Hong Kong Special Administrative Region Government proposed a total ban of e-cigarettes and HTPs
in February 2019, but the bills encountered strong opposition from the tobacco industry and had not
been approved as of May 8, 2021. Governmental approval of HTPs may encourage the tobacco
industry to market their HTPs all over the world, despite the statement that these products are not
safe. Although more research is needed to understand the short- and long-term health effects of
HTPs, prompt actions should be taken to prevent further HTP use in youth, and a total ban would be
the most effective solution.

Limitations
This study had some limitations. First, self-reported tobacco use was subject to social desirability
bias, although the anonymous questionnaire, separate answer sheet, and other procedures to instill
confidence should encourage candid reporting.21,22 The associations could be overestimated due to
recall bias if students with persistent respiratory symptoms were more likely to recall tobacco use,
but such bias would occur similarly for different tobacco products and have little effect on the
comparison between HTP and cigarette use. Second, higher risks of HTP use than cigarette use could
be explained by reverse causality if cigarette users who experienced severe respiratory symptoms
switched to HTPs. However, reverse causality cannot explain the associations between HTP use and
respiratory symptoms in never cigarette users. Third, the low response rate at school level (23%)
could lead to selection bias, although nonparticipation of schools was usually because of difficulties
in arrangements rather than smoking-related issues. Finally, although respiratory symptom is a useful
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and sensitive outcome for even short-term HTP use in youth, more serious harms may only manifest
themselves after long-term use.

Conclusions
To our knowledge, this study is the first to report that former and current HTP use in youth were
associated with respiratory symptoms, especially in never cigarette users. In former cigarette users,
respiratory symptoms were associated with current HTP use. In current cigarette users, concurrent
use of HTP was not associated with respiratory symptoms. Respiratory symptoms were more
prevalent in ever exclusive HTP users and ever dual users than ever exclusive cigarette users. The
prevalence of respiratory symptoms in exclusive current HTP users and exclusive current cigarette
users was comparable. Using HTPs instead of cigarettes may not reduce health risks. Our results lend
support to banning HTPs to protect youth health.
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